Carolina Salvador-Morales

Carolina Salvador-Morales

Auto-generated profile, based on publicly available information

Carolina Salvador-Morales

Nanodelivery Systems and Devices Branch, Cancer Imaging Program, Division of Cancer Treatment and Diagnosis National Cancer Institute, National Institutes of Health Rockville Maryland USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2018 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
BSBrian Schnoor
Brian Schnoor
AEAhmad Elhendawy
Ahmad Elhendawy
SJSuzanna Joseph
Suzanna Joseph
MPMark Putman
Mark Putman
RCRandall Chacón-Cerdas
Randall Chacón-Cerdas
CSCarolina Salvador-Morales
Carolina Salvador-Morales

21 March 2022 in ACS Nano
Verified
Journal Article
Closed access
CSCarolina Salvador-Morales
Carolina Salvador-Morales
PGPiotr Grodzinski
Piotr Grodzinski

19 January 2021 in ACS Nano
Verified
Journal Article
Closed access
LLLei Li
Lei Li
DPDeepanjali Patil
Deepanjali Patil
GPGreg Petruncio
Greg Petruncio
KHKathleen K. Harnden
Kathleen K. Harnden
JSJisha V. Somasekharan
Jisha V. Somasekharan
CSCarolina Salvador-Morales
Carolina Salvador-Morales

1 December 2014 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CMCarolina Salvador Morales
Carolina Salvador Morales
AKAli Abbas Khorasani
Ali Abbas Khorasani
JWJames L Weaver
James L Weaver
On the cusp of widespread permeation of nanomedicine, academia, industry, and government have invested substantial financial resources in developing new ways to better treat diseases. Materials have unique physical and chemical properties at the nanoscale compared with their bulk or small-molecule analogs. These unique properties have been greatly advantageous in providing innovative solutions for medical treatments at the bench level. However, nanomedicine research has not yet fully permeated the clinical setting because of several limitations. Among these limitations are the lack of universal standards for characterizing nanomaterials and the limited knowledge that we possess regarding the interactions between nanomaterials and biological entities such as proteins. In this review, we report on recent developments in the characterization of nanomaterials as well as the newest information about the interactions between nanomaterials and proteins in the human body. We propose a standard set of techniques for universal characterization of nanomaterials. We also address relevant regulatory issues involved in the translational process for the development of drug molecules and drug delivery systems. Adherence and refinement of a universal standard in nanomaterial characterization as well as the acquisition of a deeper understanding of nanomaterials and proteins will likely accelerate the use of nanomedicine in common practice to a great extent.

14 September 2023 in WIREs Nanomedicine and Nanobiotechnology
Verified
Journal Article
Closed access
CMCarolina Salvador Morales
Carolina Salvador Morales
PGPiotr Grodzinski
Piotr Grodzinski

9 June 2015 in Langmuir
Verified
Journal Article
Closed access
NRNashaat Rasheed
Nashaat Rasheed
AKAli A. Khorasani
Ali A. Khorasani
JCJuan Cebral
Juan Cebral
FMFernando Mut
Fernando Mut
RLRainald Löhner
Rainald Löhner
CSCarolina Salvador-Morales
Carolina Salvador-Morales